Recent content from Joe Carlson
Medtronic computers had been out for a full week, disrupting operations.
Costs would spike for 66,000 if Children's and Blue Cross can't agree.
Minnesota is a big player in the growing market for tools that are less invasive.
No patient harm reported from products made by Minn.'s Vascular Solutions.
A global computer outage has hurt Medtronic's ability to fulfill orders.
Blue Cross customers will not be covered there if no deal is reached by July 5.
Eden Prairie company, new partner to have a catalog of 7,000 products based in Twin Cities.
Incident happened hours after dueling protests over Islam.
In a push to increase use of its Tyrx envelope, company vows to share replacement cost should an infection set in.
Dr. Uzma Samadani is nearing a way to assess functions in real time.
India's government has ordered a big price cut; device firms are threatening to leave.
A Minneapolis firm's device is designed to help people sidelined with nerve damage regain the ability to walk
The medical device giant's guidance for year ahead is viewed by some as conservative.
The deaths occurred after patients tried to perform routine maintenance on their HeartMate II blood pump, made by the former St. Jude Medical. A "recall" notice urges that the upgrades be done in a clinic or hospital.
Hospital and medical device experts say well-meaning agencies did not coordinate attempts to provide — or always provide the most useful — information.
Experts will look to make recommendations to protect medical devices.
Patients with complex cardiac cases may benefit most from Acist Medical Systems device.
The trial between Boston Scientific and Medtronic minimally-invasive valves hints at a more competitive market.
Minnesota's IT experts had a tense and busy weekend.
Self-described whistleblower Muddy Waters accuses firm of trying to silence its critics.
Medtronic implant detects atrial fibrillation in high-risk patients.
The companies presented the results on heart devices at a Chicago conference.
Christopher M. Barry took design files to his new company when he left Lutonix.
Abbott's stimulation system can be controlled with an iPod, and is seen as the first big advancement in the U.S. in 20 years
After investing in the Maple Grove heart valve company in 2012, LivaNova is buying the company.
PraeVeni is working to implement what it calls a new test to accurately rule out the 10 most common heart problems for a fraction of the typical $4,000-plus cost of screening.
Recent FDA warning over seven patients implanted after recall could be a PR "black eye" for Abbott.
The company was faulted for failing to investigate defibrillator battery problems and cybersecurity shortcomings.
Mpls. hosted meeting to show off a brave new biotech world.
Valve was approved for use less than a year ago.
Medtronic's 670G device reads the blood-glucose level, makes a high-low prediction, then adjusts insulin dose.
Federal ruling might influence two separate whistleblower suits.
Minnesotan Nadim Yared was supposed to have one of his biggest jobs well underway just a few days into his new role as incoming chairman of the national medical-technology trade group AdvaMed.
Cardiovascular Systems Inc. was accused of hiding illegal sales tactics, but evidence was lacking.
The deal comes after the device maker halted sales of its Lotus heart valve.
But not all are sold on letting consumers purchase low-cost devices without a prescription.
The 10-year agreement is aimed at creating jointly held intellectual property.
Medtronic and St. Jude are rolling out upbeat trial results for key products.
Gillette Children's has designed a unit that helps kids recovering from surgery to move around on their own terms.
The Minnesota Department of Employment and Economic Development support is a $345,000 grant from its Job Creation Fund.
New programming makes the latest version of the device more accurate.
The plea is expected to allow Bryan Szweda to avoid jail time.
The company was already Minnesota's top biotech player. New management is thinking big.
The Lotus valve replacement system is for sale in Europe and under clinical testing in the U.S.
The medical device maker reaffirmed its full-year guidance, citing product launches in the current quarter.
The acquisition follows last year's $25 million financing round.
The FDA requires "postmarket" surveillance for medical devices. But researchers and regulators say the system is deeply flawed, exposing patients and doctors to greater risks.
Zift Medical, a startup in Fridley, believes its work can improve the process for having a brow lift
St. Jude Medical acquired the device in a 2015 deal and predicted it would be a key growth driver within five years.
Money in 2016 trailed off amid concern over fate of the Affordable Care Act.
Paul B. Pedersen was a boy of about 5, sitting next to the tar road near the family farmhouse in Ringsted, Iowa, when he had…
Adventium Labs is working on tools to help.
Medical device maker beat the forecasts, showed broad sales growth.
Regulatory approval to sell the device should boost sales and Abbott Laboratories' bottom line.
The open enrollment period to buy a 2017 health plan has been extended for one week.
David Clarke Jr. has been a popular pro-Trump commentator on Twitter and other media.
Life as a senior took many things from Irv English — teeth, independence, a sense of home — but it never took away his positive…
The device is much smaller than traditional pacemakers and can be implanted inside the heart without open-chest surgery.
FDA approval for some of its devices is on the way, company officials believe.
FDA issues warning, but patch reportedly ready.
The market will be watching closely to see if the two companies — which combined last week — can drive investment in the next technological breakthrough while managing high debt, working several other pending deals and melding differences in their corporate cultures.
Focus turns on integration teams from both companies that continue to work on the transition.
$25 billion deal is expected to become profitable for Abbott in the first year.
If you want to prevent computer hackers from attacking medical devices, it's not enough to just design the best device you can before shipping it out the door.
The closing follows months of regulatory review that required the companies to divest several proprietary devices.
Medtronic was dealt a legal setback Wednesday when a federal appeals court reinstated litigation from investment funds claiming that the medical device company misled investors…
Roseville's EnteroMedics thinks a new study will help its case with insurers.
New product can treat atrial fibrillation more quickly.
Maker of SleepSack will still use brand to market.
A "simple" plastic cap made in Maple Grove could reduce the infection rate for patients.
Outside contractor hired to replace Columbia Heights jobs.
The picture presented at a University of Minnesota event was of two scientific communities running in tandem: One is run by and for patients, focused on their immediate needs, while the other is comprised of big companies and research groups.
The pact with University Hospitals Cleveland medical Center is Medtronic's first integrated health solutions agreement in the U.S.
The company said it believes sales woes will be temporary as new products drive a recovery.
Boston is paying $210 million cash for the company, and says it's evaluating strategic options for one of EndoChoice's key products.
More from Star Tribune